CDEK by Data4ThePeople

Sign in Sign up

← All drugs Report issue

sh006

mAbexperimentalBi-specific

Clinical trial activity

0 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

0

Phase 2

0

Phase 3

0

Phase 4

0

Mechanism of action

T-cell immunoreceptor with Ig and ITIM domainsINHIBITOR
TIGIT inhibitor
- T-cell immunoreceptor with Ig and ITIM domains (TIGIT) ↗
Programmed cell death 1 ligand 1INHIBITOR
CD274 inhibitor
- Programmed cell death 1 ligand 1 (CD274) ↗

Chemistry & pharmacology

Multi-specific: Yes (Bi-specific)

Oral

No

Parenteral

No

Topical

No